Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

PTHS

Pelthos Therapeutics Inc.

Healthcare · Biological Products, (No Diagnostic Substances)

$22.40Sep 24, 2026

AI confidence 71% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for PTHS yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 0d ago

PTHS's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on PTHS.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Pelthos Therapeutics Inc. (PTHS) — events, not interpretation.

Event
Last session September 24, 2026 at $22.4.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Pelthos Therapeutics Inc. (PTHS)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for Pelthos Therapeutics Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$85.76M
Revenue:
$15.60M

PTHS earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Pelthos Therapeutics Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.